Drug-induced nephropathies.
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001241:Aspirin / Q000009:adverse effects; D003085:Colic / Q000150:complications; D003165:Complement System Proteins; D005919:Glomerular Filtration Rate; D005921:Glomerulonephritis / Q000139:chemically induced; D006046:Gold / Q000009:adverse effects; D006417:Hematuria / Q000150:complications; D006600:Hexosephosphates / Q000037:antagonists & inhibitors; D006801:Humans; D006973:Hypertension / Q000150:complications; D007074:Immunoglobulin G; D007674:Kidney Diseases / Q000139:chemically induced*; D009404:Nephrotic Syndrome / Q000139:chemically induced; D010396:Penicillamine / Q000009:adverse effects; D010437:Peptic Ulcer / Q000150:complications; D010615:Phenacetin / Q000009:adverse effects / Q000378:metabolism; D011448:Prostaglandin Antagonists; D011507:Proteinuria / Q000150:complications; D051381:Rats; D014552:Urinary Tract Infections / Q000150:complications
D006600:Hexosephosphates; D007074:Immunoglobulin G; D011448:Prostaglandin Antagonists; D006046:Gold; D003165:Complement System Proteins; D010615:Phenacetin; D010396:Penicillamine; D001241:Aspirin